Preclinical/Co-Clinical Section

Information

  • Research Project
  • 10251355
  • ApplicationId
    10251355
  • Core Project Number
    U54OD030187
  • Full Project Number
    5U54OD030187-02
  • Serial Number
    030187
  • FOA Number
    PAR-20-085
  • Sub Project Id
    6034
  • Project Start Date
    9/1/2020 - 4 years ago
  • Project End Date
    8/31/2025 - 6 months from now
  • Program Officer Name
  • Budget Start Date
    9/1/2021 - 3 years ago
  • Budget End Date
    8/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    8/13/2021 - 3 years ago

Preclinical/Co-Clinical Section

PROJECT SUMMARY PRECLINICAL/CO-CLINICAL CORE The Jackson Laboratory (JAX) and The Jackson Laboratory Center for Precision Genetics (JCPG) occupy a unique niche within the global biomedical research community. Although we do not see patients, many of these individuals have benefited from our stewardship of the thousands of different mouse strains that JAX provides for use in human disease research. And it is not just our mice; our faculty researchers, with deep expertise in genetics and mammalian biology, collaborate directly with investigators at hospitals, medical centers and an array of other clinically oriented partners worldwide. Thus, the JCPG will operate using a ?hub and spokes? concept where the JCPG forms part of a mammalian disease model ?hub? that integrates a variety of JAX resources to establish an array of collaborative ?spokes? with a variety of partners to co-produce precise preclinical disease models. The Preclinical/Co-clinical core of the JCPG will work with expert clinical, patient, research and industry collaborators to facilitate optimal creation and application of existing and nominated projects. Together with the JCPG Coordination Core, the Preclinical/Co-clinical Core and the Steering Committee will apply a series of benchmark standards to work toward the eventual goal of translation into clinical practice. Ultimately, we will further extend our impact by providing a more advanced Fee for Service approach to broaden community access to JAX resources. To meet current goals of the JCPG and to refine and expand its future operation, the Preclinical/Co-clinical Core will: 1) Solicit, evaluate and prioritize new preclinical/co-clinical project requests and provide recommendations to the Steering Committee for adoption by the JCPG. 2) Advance new models through the production-like pipelines, with characterization and drug testing so they can more tangibly inform future clinical applications. 3) Continue to develop and expand existing JAX infrastructure to facilitate access to clinical data and samples, supporting data exchange between mouse information and patient data.

IC Name
OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH
  • Activity
    U54
  • Administering IC
    OD
  • Application Type
    5
  • Direct Cost Amount
    88968
  • Indirect Cost Amount
    62278
  • Total Cost
  • Sub Project Total Cost
    151246
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    OD:151246\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    JACKSON LABORATORY
  • Organization Department
  • Organization DUNS
    042140483
  • Organization City
    BAR HARBOR
  • Organization State
    ME
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    046091523
  • Organization District
    UNITED STATES